Qualitative Properties of Circulating Fatty Acids Are Associated With MASLD : A Cross‐Sectional Study From the NHANES Database
Liver International · 2025
DOI: 10.1111/liv.70441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Stefano Ciardullo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Rehabilitation, Policlinico di Monza, Monza, Italy. Hauptthemen laut MEDLINE: Fatty Acids, Fatty Liver, Liver Cirrhosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objective The role of circulating fatty acids (FA) as well as the association between their composition and metabolic dysfunction‐associated steatotic liver disease (MASLD) is not known. Here, we evaluate the association between specific FA subtypes and both MASLD and liver fibrosis in a general population setting.
Methods
In this cross‐sectional study, serum levels of FAs were measured after an overnight fast in a representative sample of the general US population. Concentrations of total FA were assessed using capillary gas chromatography coupled with negative‐ion mass spectrometry. They were divided into saturated (palmitic, stearic and butyric acid), monounsaturated (palmitoleic and oleic acid), ω‐6 polyunsaturated (ω‐6 PUFA: linoleic and arachidonic acid) and ω‐3 PUFA (alpha‐linolenic, docosanoic [DHA] and eicosapentaenoic [EPA] acid). Explorative end points were: insulin resistance, liver steatosis and fibrosis estimated using the Homeostatic Model of Insulin Resistance (HOMA‐IR), a fatty liver index (FLI) score ≥ 60 and a Fibrosis 4 (FIB‐4) score ≥ 1.3, respectively. Logistic regression analyses were performed to assess their associations with different FAs after adjustment for confounders.
Results
A total of 2440 people were included in the study. Concentrations of all considered FAs increased progressively across HOMA‐IR quartiles. A similar trend was identified when the population was segregated according to FLI. In logistic regression analyses adjusted for age, sex, body mass index and race‐ethnicity, when evaluated as a percentage of all circulating FAs, linoleic acid, arachidonic acid and DHA were inversely associated with insulin resistance and liver steatosis. Finally, only alpha‐linolenic acid was associated with a lower risk of liver fibrosis (OR: 0.48, 95% CI 0.25–0.93, p = 0.031).
Conclusions
This study provides initial epidemiologic evidence in humans that ω‐3 PUFA in particular are associated with a lower risk of liver steatosis and alpha‐linolenic acid in particular was also protective against fibrosis, supporting data in animal models. Moreover, their circulating levels might be manipulated using nutritional strategies in clinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Rehabilitation, Policlinico di Monza, Monza, Italy.
- Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.
ORCID-Profile: Gianluca Perseghin
Zitieren
APA
Ciardullo, S., Vergani, M., Rizzo, M., Oltolini, A., Bongo, A., Muraca, E., & Perseghin, G. (2025). Qualitative Properties of Circulating Fatty Acids Are Associated With MASLD : A Cross‐Sectional Study From the NHANES Database. Liver International. https://doi.org/10.1111/liv.70441
Vancouver
Ciardullo S, Vergani M, Rizzo M, Oltolini A, Bongo A, Muraca E, et al. Qualitative Properties of Circulating Fatty Acids Are Associated With MASLD : A Cross‐Sectional Study From the NHANES Database. Liver International. 2025. doi:10.1111/liv.70441
BibTeX
@article{Ciardullo2025,
author = {Ciardullo, Stefano and Vergani, Michela and Rizzo, Mariangela and Oltolini, Alice and Bongo, Alessia and Muraca, Emanuele and Perseghin, Gianluca},
title = {Qualitative Properties of Circulating Fatty Acids Are Associated With MASLD : A Cross‐Sectional Study From the NHANES Database},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.70441}
}
EUVIMED